Announcements Trials

Browse Landscape

Phase

Phase 2 52 Phase 1 52 Phase 1/2 20 Phase 3 5 Phase NA 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 23 Metformin 14 pembrolizumab 12 Radiotherapy 12 Biopsy 11 Nivolumab 9 Fluorouracil 9 Cyclophosphamide 9 Temozolomide 7 Radiation 7 Bevacizumab 7 gallium 68 PSMA-11 6 Sirolimus 6 Rituximab 6 Letrozole 6 Etoposide 6 Cisplatin 6 Aspirin 6 olaparib 5 Surveys and Questionnaires 5 Radiosurgery 5 Oxaliplatin 5 Irinotecan 5 Indocyanine Green 5 Granulocyte Colony-Stimulating Factor 5 Fluorodeoxyglucose F18 5 Dexamethasone 5 aldesleukin 4 Surgical Procedures, Operative 4 Proflavine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × temsirolimus × Clear all

NCT01417065 2014-06-23

Temsirolimus In Phase 0

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡